` VIMIAN (Vimian Group AB) vs OMX Stockholm 30 Comparison - Alpha Spread

V
VIMIAN
vs
O
OMX Stockholm 30

Over the past 12 months, VIMIAN has outperformed OMX Stockholm 30, delivering a return of +7% compared to the OMX Stockholm 30's +1% growth.

Stocks Performance
VIMIAN vs OMX Stockholm 30

Loading
VIMIAN
OMX Stockholm 30
Add Stock
www.alphaspread.com

Performance Gap
VIMIAN vs OMX Stockholm 30

Loading
VIMIAN
OMX Stockholm 30
Difference
www.alphaspread.com

Performance By Year
VIMIAN vs OMX Stockholm 30

Loading
VIMIAN
OMX Stockholm 30
Add Stock

Competitors Performance
Vimian Group AB vs Peers

OMX Stockholm 30
VIMIAN
ALC
7741
COLO B
ALGN
Add Stock

Vimian Group AB
Glance View

Market Cap
19.3B SEK
Industry
Health Care

Vimian Group AB is a relatively new player making waves in the veterinary and animal health industries. Founded in Sweden, Vimian is structured as a conglomerate composed of specialized subsidiaries focused on different niche markets within veterinary services, diagnostics, and technology. This strategic structure enables the company to operate across various segments such as Veterinary Services, Specialty Pharma, MedTech, and Diagnostics, achieving a holistic approach to animal healthcare. By acquiring and partnering with innovative companies globally, Vimian capitalizes on synergies and cross-market opportunities, ensuring a competitive edge in each of its operational fields. The company’s diverse portfolio allows it to cater not only to pet owners and veterinary professionals but also to livestock industries, ensuring comprehensive coverage in the growing market of animal welfare and health. Vimian’s revenue streams are multi-faceted, generated from a blend of product sales, subscriptions, and service fees. For instance, within its Specialty Pharma segment, the company develops and sells pharmaceutical products designed to treat common and specialty conditions in animals, thus generating continuous revenue from veterinary practices worldwide. In the MedTech segment, Vimian offers cutting-edge medical devices and equipment, enhancing veterinary surgical and diagnostic capabilities, which drives sales. Meanwhile, their Diagnostics division provides innovative testing solutions that help veterinarians identify and treat animal diseases accurately, offering another lucrative revenue stream. This multi-pronged business model not only mitigates risk through diversification but also positions Vimian as a key player in meeting the rapidly evolving demands of animal health and care.

VIMIAN Intrinsic Value
47.87 SEK
Undervaluation 23%
Intrinsic Value
Price
V
Back to Top